Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or the “Company”), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today closed its previously announced registered direct offering for the purchase of an aggregate of 12,000,000 shares of its common stock and accompanying warrants to purchase up to an aggregate of […]
Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that that members of its senior leadership team will present at the Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum on November 21, 2024 at 9:00 am EST in New York City. The team
Merchants Bancorp (“Merchants”) (Nasdaq: MBIN), a holding company that operates through its wholly owned subsidiary, Merchants Bank of Indiana (“Merchants Bank”), announced the pricing of an underwritten public offering of 9,200,000 depositary shares, each representing a 1/40th ownership interest in a share of its 7.625% Fixed Rate Series E Non-Cumulative Perpetual Preferred Stock (the “Series
MillerKnoll, Inc. (NASDAQ: MLKN) will announce its financial results for the second quarter of fiscal year 2025 on Wednesday, December 18, 2024, after the stock market closes. The same day, the Company will host a conference call and webcast to discuss results at 5:00 p.m. Eastern time. https://mma.prnewswire.com/media/2348253/MillerKnoll_Logo.jpg Participants may access the conference call live
Tuya Inc. (“Tuya” or the “Company”) (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights — Total revenue was US$81.6 million, up approximately 33.6% year over year (3Q2023: US$61.1 million). — IoT platform-as-a-service (“PaaS”)
— Industry veteran with extensive experience in key areas of focus — Interim-CFO Richard Narido to focus on HOPE Therapeutics acquisition opportunities NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced it has appointed Michael Abrams as its permanent Chief Financial Officer. Mr. Abrams succeedsInterim-CFO Richard Narido, who will
TheAndersons, Inc. (Nasdaq: ANDE) announces that it will present at the Stephens Annual Investment Conference on Wednesday, November 20, 2024. https://mma.prnewswire.com/media/74436/THE_ANDERSONS_LOGO.jpg President and Chief Executive Officer Bill Krueger and Executive Vice President and Chief Financial Officer Brian Valentine will speak at the conference at 8 a.m. Central Time. The Andersons presentation will be broadcast live
— Video Footage Shows HyperSport Delivering Game-Changing Performance — Up to 200 hp, 200 mph, and 200 miles of range — Company's Proprietary EV Platform Showcased in Action — Maker of high-tech, high-performance motorcycles that are safer, smarter, and cleaner Damon Inc. (Nasdaq: DMN), maker of high-tech, high-performance motorcycles that are safer, smarter, and cleaner
MongoDB, Inc. (NASDAQ: MDB) today announced it will report its third quarter fiscal year 2025 financial results for the three months ended October 31, 2024, after the U.S. financial markets close on Monday, December 9, 2024. https://mma.prnewswire.com/media/384058/MongoDB_Logo.jpg In conjunction with this announcement, MongoDB will host a conference call on Monday, December 9, 2024, at 5:00
Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or the “Company”), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today closed its previously announced registered direct offering for the purchase of an aggregate of 12,000,000 shares of its common stock and accompanying warrants to purchase up to an aggregate of